{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:11:10Z","timestamp":1774984270354,"version":"3.50.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.semarthrit.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T10:39:26Z","timestamp":1565433566000},"page":"156-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["AA amyloidosis secondary to adult onset Still's disease: About 19 cases"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"Delplanque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pouchot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ducharme-B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Benyamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"mars 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0001","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"issue":"f\u00e9vr 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/07853890.2014.971052","article-title":"Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options","volume":"47","author":"Kadavath","year":"2015","journal-title":"Ann Med"},{"issue":"mars 3","key":"10.1016\/j.semarthrit.2019.08.005_bib0003","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"mai 3","key":"10.1016\/j.semarthrit.2019.08.005_bib0004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"avr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"juin 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0006","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nephro.2017.03.001","article-title":"[AA amyloidosis]","volume":"13","author":"Stojanovic","year":"2017","journal-title":"Nephrol Ther"},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the prisma statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"nov 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.amjmed.2003.04.001","article-title":"Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease","volume":"115","author":"Serratrice","year":"2003","journal-title":"Am J Med"},{"issue":"juin 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0009","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9343(80)90201-6","article-title":"Adult Still's disease","volume":"68","author":"Esdaile","year":"1980","journal-title":"Am J Med"},{"issue":"juin 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780250607","article-title":"Adult-onset Still's disease. twenty-year followup and further studies of patients with active disease","volume":"25","author":"Elkon","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"mars 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00005792-198403000-00002","article-title":"Adult Still's disease. evolution of a clinical syndrome and diagnosis, treatment, and follow-up of 17 patients","volume":"63","author":"Larson","year":"1984","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.08.005_bib0012","first-page":"406","article-title":"[Amyloidosis in adult Still's disease. apropos of 2 cases]","volume":"137","author":"Vigneron","year":"1986","journal-title":"Ann Med Interne (Paris)"},{"issue":"ao\u00fbt 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-0172(87)90015-1","article-title":"Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure","volume":"17","author":"Reginato","year":"1987","journal-title":"Semin Arthritis Rheum"},{"issue":"nov 235","key":"10.1016\/j.semarthrit.2019.08.005_bib0014","first-page":"1055","article-title":"Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"Q J Med"},{"issue":"f\u00e9vr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease. clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"juin 3","key":"10.1016\/j.semarthrit.2019.08.005_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0248-8663(89)80005-0","article-title":"[Adult Still's disease. A too often unrecognized illness. A study of a series of 11 cases]","volume":"10","author":"Flipo","year":"1989","journal-title":"Rev Med Interne"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.49.5.283","article-title":"Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years","volume":"49","author":"Cabane","year":"1990","journal-title":"Ann Rheum Dis"},{"issue":"ao\u00fbt 8","key":"10.1016\/j.semarthrit.2019.08.005_bib0018","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"issue":"mars 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"d\u00e9c 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF02283110","article-title":"Adult onset Still's disease: clinical features and course","volume":"11","author":"S\u00e1nchez Loria","year":"1992","journal-title":"Clin Rheumatol"},{"issue":"juin 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0021","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/31.6.417","article-title":"Adult-onset Still's disease in India","volume":"31","author":"Singh","year":"1992","journal-title":"Br J Rheumatol"},{"issue":"avr 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0022","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.51.4.529","article-title":"Adult onset Still's disease: clinical experience with 18 patients over 15 years in northern India","volume":"51","author":"Bambery","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"mars 3","key":"10.1016\/j.semarthrit.2019.08.005_bib0023","first-page":"495","article-title":"Comparative study of 6 types of criteria in adult Still's disease","volume":"23","author":"Masson","year":"1996","journal-title":"J Rheumatol"},{"issue":"d\u00e9c 12","key":"10.1016\/j.semarthrit.2019.08.005_bib0024","first-page":"2345","article-title":"Clinical characteristics, treatment, and outcome of adult onset Still's disease in southern Chinese","volume":"25","author":"Mok","year":"1998","journal-title":"J Rheumatol"},{"issue":"oct 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0025","first-page":"301","article-title":"Adult onset Still's disease: clinical features and outcome in 16 Thai patients","volume":"7","author":"Louthrenoo","year":"2001","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.08.005_bib0026","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s100670170065","article-title":"Adult-Onset Still's disease in Saudi Arabia","volume":"20","author":"Al-Arfaj","year":"2001","journal-title":"Clin Rheumatol"},{"issue":"avr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0027","first-page":"76","article-title":"Adult-onset Still disease in southeast Brazil","volume":"11","author":"Appenzeller","year":"2005","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"sept 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0028","first-page":"639","article-title":"A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis","volume":"25","author":"Pay","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"oct 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0029","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/03009740600709816","article-title":"Long-term follow-up of patients with adult-onset Still's disease","volume":"35","author":"Akritidis","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"f\u00e9vr 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009740510026616","article-title":"Epidemiology and outcome of adult-onset Still's disease in Northern Norway","volume":"35","author":"Evensen","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"10\u201311","key":"10.1016\/j.semarthrit.2019.08.005_bib0031","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.rhum.2006.10.610","article-title":"La maladie de Still: \u00e0 propos de 19 cas","volume":"73","author":"Marzouk","year":"2006","journal-title":"Rev Rhum"},{"issue":"juin 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0032","first-page":"461","article-title":"[Adult onset Still's disease: about 11 cases]","volume":"85","author":"Cheikhrouhou Abdelmoula","year":"2007","journal-title":"Tunis Med"},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0033","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-006-0440-x","article-title":"Ten years of clinical experience with adult onset Still's disease: is the outcome improving?","volume":"26","author":"Uppal","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"janv 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10067-007-0648-4","article-title":"Adult onset Still's disease: a study of 14 cases","volume":"27","author":"Singh","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.08.005_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/s10165-008-0104-6","article-title":"Adult-onset Still's disease: a report of 28 cases and review of the literature","volume":"18","author":"Mehrpoor","year":"2008","journal-title":"Mod Rheumatol"},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0036","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1742-1241.2007.01393.x","article-title":"Adult-onset Still's disease","volume":"63","author":"Cagatay","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"sept 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0037","first-page":"284","article-title":"Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients","volume":"15","author":"Zhu","year":"2009","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0038","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.080365","article-title":"Clinical features and prognosis of adult-onset Still's disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J Rheumatol"},{"issue":"janv 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0039","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3899\/jrheum.080537","article-title":"The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease","volume":"36","author":"Lee","year":"2009","journal-title":"J Rheumatol"},{"issue":"mai 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13317-010-0009-1","article-title":"Adult-onset Still disease: a rare disorder with a potentially fatal outcome","volume":"1","author":"Priori","year":"2010","journal-title":"Auto- Immun Highlights"},{"issue":"sept 9","key":"10.1016\/j.semarthrit.2019.08.005_bib0041","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10067-010-1516-1","article-title":"Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases","volume":"29","author":"Kong","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"avr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0042","first-page":"331","article-title":"Adult onset Still's disease: review of 41 cases","volume":"29","author":"Riera","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"avr 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0043","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3899\/jrheum.100766","article-title":"Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population","volume":"38","author":"Jiang","year":"2011","journal-title":"J Rheumatol"},{"issue":"ao\u00fbt 8","key":"10.1016\/j.semarthrit.2019.08.005_bib0044","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","article-title":"Therapeutic responses and prognosis in adult-onset Still's disease","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol Int"},{"issue":"f\u00e9vr 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0046","first-page":"47","article-title":"Adult-onset Still's disease: clinical, serological and therapeutic considerations","volume":"31","author":"Iliou","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"mars 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0047","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"f\u00e9vr 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0048","first-page":"28","article-title":"Clinical features and prognosis in 82 patients with adult-onset Still's disease","volume":"32","author":"Kim","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"sept 9","key":"10.1016\/j.semarthrit.2019.08.005_bib0049","first-page":"16634","article-title":"Clinical features and prognosis of adult-onset Still's disease: 75 cases from China","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"mai","key":"10.1016\/j.semarthrit.2019.08.005_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","article-title":"Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: data from a large multicenter cohort","volume":"69","author":"Kalyoncu","year":"2016","journal-title":"J Autoimmun"},{"issue":"d\u00e9c 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0051","first-page":"818","article-title":"Epidemiology and outcome of adult-onset Still's disease in Northwestern Thrace region in Turkey","volume":"33","author":"Balci","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"d\u00e9c 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0052","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med."},{"issue":"oct 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0053","first-page":"833","article-title":"Amyloidosis in adult onset Still's disease","volume":"8","author":"Harrington","year":"1981","journal-title":"J Rheumatol"},{"issue":"avr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0054","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02776678","article-title":"Improvement of endoscopic and histologic findings of AA-type gastrointestinal amyloidosis by treatment with dimethyl sulfoxide and prednisolone","volume":"20","author":"Takahashi","year":"1985","journal-title":"Gastroenterol Jpn"},{"issue":"juin 8","key":"10.1016\/j.semarthrit.2019.08.005_bib0055","first-page":"630","article-title":"[Secondary amylosis in Still's disease in an adult. value of biopsy of the subcutaneous abdominal fatty tissue]","volume":"55","author":"Horlait","year":"1988","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"avr 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0056","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.50.4.257","article-title":"Adult onset Still's disease and related renal amyloidosis","volume":"50","author":"Wendling","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"janv 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0057","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2169\/internalmedicine.32.50","article-title":"Systemic amyloidosis in a patient with adult onset Still's disease","volume":"32","author":"Ishii","year":"1993","journal-title":"Intern Med Tokyo Jpn"},{"issue":"ao\u00fbt 8","key":"10.1016\/j.semarthrit.2019.08.005_bib0058","first-page":"1714","article-title":"Vascular renal AA amyloidosis in adult Still's disease","volume":"12","author":"Rivera","year":"1997","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"f\u00e9vr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0059","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"issue":"juill 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3904\/kjim.2000.15.2.131","article-title":"Secondary renal amyloidosis in adult onset Still's disease: case report and review of the literature","volume":"15","author":"Oh","year":"2000","journal-title":"Korean J Intern Med"},{"issue":"sept 9","key":"10.1016\/j.semarthrit.2019.08.005_bib0061","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.revmed.2004.04.025","article-title":"[Amyloidosis in adult onset Still's disease]","volume":"25","author":"Ben Ghorbel","year":"2004","journal-title":"Rev Med Interne"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0062","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00535-006-1792-3","article-title":"Oral dimethyl sulfoxide for systemic amyloid a amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review","volume":"41","author":"Amemori","year":"2006","journal-title":"J Gastroenterol"},{"issue":"avr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0063","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/s10165-010-0365-8","article-title":"Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis","volume":"21","author":"Kishida","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"sept 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0064","first-page":"699","article-title":"Secondary bladder amyloidosis: a new case report","volume":"65","author":"Benito","year":"2012","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.semarthrit.2019.08.005_bib0065","unstructured":"Tamesis ER, Reginato AM, Hubscher O, Reginato AJ. Etanercept in recalcitrant adult onset Still's disease. 2000;"},{"issue":"oct 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0066","first-page":"330","article-title":"Successful treatment of a patient with refractory adult-onset still disease with anakinra","volume":"9","author":"Rudinskaya","year":"2003","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.08.005_bib0067","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/s10165-008-0116-2","article-title":"A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years","volume":"19","author":"Nakahara","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"ao\u00fbt 8","key":"10.1016\/j.semarthrit.2019.08.005_bib0068","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.48.8.696","article-title":"Amyloidosis in the rheumatic diseases","volume":"48","author":"Dhillon","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"ao\u00fbt 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0069","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/art.1780210615","article-title":"The amyloidosis of juvenile rheumatoid arthritis\u2013comparative studies in Polish and American children. I. Levels of serum SAA protein","volume":"21","author":"Filipowicz-Sosnowska","year":"1978","journal-title":"Arthritis Rheum"},{"issue":"f\u00e9vr 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0070","first-page":"85","article-title":"Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study","volume":"11","author":"David","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"ao\u00fbt 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0071","first-page":"431","article-title":"Juvenile chronic arthritis in a Turkish population","volume":"9","author":"Ozdogan","year":"1991","journal-title":"Clin Exp Rheumatol"},{"issue":"oct 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0072","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/03009740701340339","article-title":"Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland?","volume":"36","author":"Immonen","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0073","first-page":"907","article-title":"Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis","volume":"35","author":"Immonen","year":"2008","journal-title":"J Rheumatol"},{"issue":"mars 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0074","first-page":"25","article-title":"A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland","volume":"18","author":"Immonen","year":"2011","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"nov 6","key":"10.1016\/j.semarthrit.2019.08.005_bib0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/03009741003747481","article-title":"More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases","volume":"39","author":"Vasala","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0076","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"janv 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0077","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/rheumatology\/ket250","article-title":"Biologic treatments for adult-onset Still's disease","volume":"53","author":"Al-Homood","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"issue":"juin 23","key":"10.1016\/j.semarthrit.2019.08.005_bib0078","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med."},{"issue":"d\u00e9c 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0079","first-page":"262","article-title":"Amyloidosis is frequently undetected in patients with rheumatoid arthritis","volume":"15","author":"Koivuniemi","year":"2008","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.08.005_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0248-8663(00)87227-6","article-title":"Mechanisms of amyloidosis and the proteins involved","volume":"21","author":"Lebrazi","year":"2000","journal-title":"Rev Med Interne"},{"issue":"juill 9275","key":"10.1016\/j.semarthrit.2019.08.005_bib0081","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet Lond Engl."},{"issue":"d\u00e9c 12","key":"10.1016\/j.semarthrit.2019.08.005_bib0082","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.1780381220","article-title":"Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine","volume":"38","author":"Shapiro","year":"1995","journal-title":"A case report. Arthritis Rheum"},{"issue":"nov 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0083","first-page":"E7","article-title":"Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate","volume":"32","author":"Komatsuda","year":"1998","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0084","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/41.7.833","article-title":"Treatment of AA amyloid with chlorambucil","volume":"41","author":"Ortiz-Santamar\u00eda","year":"2002","journal-title":"Rheumatol Oxf Engl"},{"issue":"avr 16","key":"10.1016\/j.semarthrit.2019.08.005_bib0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med."},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0086","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/40.7.821","article-title":"Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide","volume":"40","author":"Chevrel","year":"2001","journal-title":"Rheumatol Oxf Engl"},{"issue":"juill 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0087","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10067-005-0048-6","article-title":"Renal amyloidosis: an uncommon complication of juvenile idiopathic arthritis","volume":"25","author":"Duarte","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"juin 3","key":"10.1016\/j.semarthrit.2019.08.005_bib0088","first-page":"178","article-title":"Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis","volume":"4","author":"De La Torre","year":"2011","journal-title":"NDT Plus"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0089","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12098-015-1913-1","article-title":"Systemic juvenile idiopathic arthritis with amyloidosis: an uncommon complication with a favourable outcome","volume":"83","author":"Sharma","year":"2016","journal-title":"Indian J Pediatr"},{"issue":"avr 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00467-015-3249-5","article-title":"Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases","volume":"31","author":"Topaloglu","year":"2016","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"mai 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0091","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12882-017-0573-y","article-title":"Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review","volume":"18","author":"Chantarogh","year":"2017","journal-title":"BMC Nephrol."},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0092","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0093","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amjmed.2009.11.010","article-title":"Long-term TNF-alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases","volume":"123","author":"Fern\u00e1ndez-Nebro","year":"2010","journal-title":"Am J Med"},{"issue":"ao\u00fbt 34","key":"10.1016\/j.semarthrit.2019.08.005_bib0094","doi-asserted-by":"crossref","first-page":"e7859","DOI":"10.1097\/MD.0000000000007859","article-title":"Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: a STROBE-compliant observational study","volume":"96","author":"Esatoglu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.08.005_bib0095","first-page":"84","article-title":"AA amyloidosis treated with tocilizumab: case series and updated literature review","volume":"22","author":"Courties","year":"2015","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"sept 3","key":"10.1016\/j.semarthrit.2019.08.005_bib0096","first-page":"189","article-title":"Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"avr","key":"10.1016\/j.semarthrit.2019.08.005_bib0097","first-page":"1","article-title":"Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis","volume":"27","author":"Varan","year":"2018","journal-title":"Mod Rheumatol."},{"issue":"ao\u00fbt 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0098","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0272-6386(03)00676-0","article-title":"Long-term outcome of live donor kidney transplantation for renal amyloidosis","volume":"42","author":"Sherif","year":"2003","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"mars 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0099","first-page":"15","article-title":"Fifteen years\u2019 experience with renal transplantation in systemic amyloidosis","volume":"5","author":"Hartmann","year":"1992","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"issue":"avr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ckj\/sfs019","article-title":"AA amyloidosis in the renal allograft: a report of two cases and review of the literature","volume":"5","author":"Rojas","year":"2012","journal-title":"Clin Kidney J"},{"issue":"ao\u00fbt 8","key":"10.1016\/j.semarthrit.2019.08.005_bib0101","first-page":"812","article-title":"Recurrence from primary and secondary glomerulopathy after renal transplant","volume":"25","author":"Canaud","year":"2012","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"issue":"mars 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/ard.27.2.137","article-title":"Mortality and prognosis related to the amyloidosis of Still's disease","volume":"27","author":"Smith","year":"1968","journal-title":"Ann Rheum Dis"},{"issue":"mai 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0103","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/1744666X.2018.1465821","article-title":"Complications of adult-onset Still's disease and their management","volume":"14","author":"Mitrovic","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"janv 1","key":"10.1016\/j.semarthrit.2019.08.005_bib0104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients","volume":"89","author":"Hot","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"janv 4","key":"10.1016\/j.semarthrit.2019.08.005_bib0105","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1097\/MD.0000000000000451","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients","volume":"94","author":"Bae","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"d\u00e9c 12","key":"10.1016\/j.semarthrit.2019.08.005_bib0106","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"oct 5","key":"10.1016\/j.semarthrit.2019.08.005_bib0107","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"f\u00e9vr 2","key":"10.1016\/j.semarthrit.2019.08.005_bib0108","first-page":"308","article-title":"Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation","volume":"30","author":"Gershoni-Baruch","year":"2003","journal-title":"J Rheumatol"},{"issue":"juill 7","key":"10.1016\/j.semarthrit.2019.08.005_bib0109","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00296-014-3205-x","article-title":"Predictors of AA amyloidosis in familial Mediterranean fever","volume":"35","author":"Mukhin","year":"2015","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.08.005_bib0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/ar78","article-title":"Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue","volume":"2","author":"O'Hara","year":"2000","journal-title":"Arthritis Res"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219302458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219302458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:01:56Z","timestamp":1758733316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017219302458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0049017219302458"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.08.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AA amyloidosis secondary to adult onset Still's disease: About 19 cases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}